Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
| Autor: | Hideki Wakasugi, Yasuhisa Shinomura, Yasutaka Sukawa, Hiroki Takahashi, Motohisa Yamamoto, Chisako Suzuki, Kohzoh Imai, Hiroyuki Yamamoto, Yasuyoshi Naishiro, Mayuko Saito |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Pediatrics Arthritis Severity of Illness Index Receptors Tumor Necrosis Factor Etanercept Arthritis Rheumatoid Leukoencephalopathy Rheumatology Internal medicine Severity of illness medicine Humans Coma Aged Tumor Necrosis Factor-alpha business.industry Progressive multifocal leukoencephalopathy Leukoencephalopathy Progressive Multifocal medicine.disease Magnetic Resonance Imaging Surgery Immunoglobulin G Rheumatoid arthritis Dementia Female Polyarthritis business Immunosuppressive Agents medicine.drug |
| Zdroj: | Modern Rheumatology. 17:72-74 |
| ISSN: | 1439-7609 1439-7595 |
| DOI: | 10.3109/s10165-006-0530-2 |
| Popis: | A 74-year-old Japanese woman was diagnosed with rheumatoid arthritis due to polyarthralgia. She was prescribed various disease-modifying anti-rheumatic drugs, but most of them were discontinued because of side effects or poor effectiveness. She was referred to our hospital in 2004, and etanercept was administered from June 2005. This resulted in rapid improvement of polyarthritis; however, she developed disorientation from February 2006. She was admitted to our hospital because of convulsions and loss of consciousness. She was diagnosed with progressive multifocal leukoencephalopathy on the basis of clinical symptoms and magnetic resonance imaging of the brain. In this significant and important case, leukoencephalopathy occurred during etanercept administration, and we refer to the risk of anti-TNFalpha drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink